GeneDx Holdings Corp. Gain (Loss) Related to Litigation Settlement
GeneDx Holdings Corp. (WGS) reported Gain (Loss) Related to Litigation Settlement of -$5.56 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-02-23
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for the quarter ending 2025-12-31 was -$4.75M, a 139.18% decline year-over-year.
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for the quarter ending 2025-09-30 was -$810.00K, a 161.04% decline year-over-year.
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for the quarter ending 2024-12-31 was $12.12M.
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for the quarter ending 2024-09-30 was $1.33M.
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for fiscal 2025 was -$5.56M.
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for fiscal 2024 was $0.00.
- GeneDx Holdings Corp. gain (loss) related to litigation settlement for fiscal 2023 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$5.56M derived: sum of 2 quarters · filed 2026-02-23 | -$5.56M 10-K · filed 2026-02-23 | |
| 2025-09-30 | -$810.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$810.00K 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-29 | |||
| 2024-12-31 | $12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $13.45M derived: sum of 2 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 | |
| 2024-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$12.12M 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | -$13.45M 10-Q · filed 2025-07-29 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |